Zhejiang Changming Pharmaceutical Co., Ltd.

Zhejiang
Categories
Contact Supplier
  • From:
  • To:
    Zhejiang Changming Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)
  • Verification:
Company Profile
Zhejiang

Zhejiang Changming Pharmaceutical Co., Ltd, established in 2006, is the subsidiary of Zhejiang Shengda Group. Changming specializes in research, development, production and marketing of cardiovascular and other therapeutic drug related APls and intermediates. Changming is one of leading suppliers of pharmaceutical grade ACE inhibitor APIs and intermediates. The leading products include: Enalapril, Ramipril, Lisinopril, Benfotiamine, Doxofylline,etc.

more >

Year of Establishment: 2006

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: 100-500

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    Zhejiang Changming Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service